The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status

Supplemental Digital Content is available in the text Objective: To examine the prognostic impact of tumor laterality in colon cancer liver metastases (CLM) after stratifying by Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) mutational status. Background: Although some studies have demonstrated that patients with CLM from a right sided (RS) primary cancer fare worse, others have found equivocal outcomes of patients with CLM with RS versus left-sided (LS) primary tumors. Importantly, recent evidence from unresectable metastatic CRC suggests that tumor laterality impacts prognosis only in those with wild-type tumors. Methods: Patients with rectal or transverse colon tumors and those with unknown KRAS mutational status were excluded from analysis. The prognostic impact of RS versus LS primary CRC was determined after stratifying by KRAS mutational status. Results: 277 patients had a RS (38.6%) and 441 (61.4%) had a LS tumor. Approximately one-third of tumors (28.1%) harbored KRAS mutations. In the entire cohort, RS was associated with worse 5-year overall survival (OS) compared with LS (39.4% vs 50.8%, P = 0.03) and remained significantly associated with worse OS in the multivariable analysis (hazard ratio 1.45, P = 0.04). In wild-type patients, a worse 5-year OS associated with a RS tumor was evident in univariable analysis (43.7% vs 55.5%, P = 0.02) and persisted in multivariable analysis (hazard ratio 1.49, P = 0.01). In contrast, among patients with KRAS mutated tumors, tumor laterality had no impact on 5-year OS, even in the univariable analysis (32.8% vs 34.0%, P = 0.38). Conclusions: This study demonstrated, for the first time, that the prognostic impact of primary tumor side differs according to KRAS mutational status. RS tumors were associated with worse survival only in patients with wild-type tumors.

[1]  F. Makowiec,et al.  Does the site of primary colorectal cancer influence the outcome after resection of isolated liver metastases? , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  R. Weigel,et al.  The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases , 2018, Journal of Gastrointestinal Surgery.

[3]  J. Tabernero,et al.  Effect of Primary Tumor Location on Second‐ or Later‐line Treatment Outcomes in Patients With RAS Wild‐type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies , 2018, Clinical colorectal cancer.

[4]  M. Rugge,et al.  Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer? , 2018, The oncologist.

[5]  P. Lønning,et al.  Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer , 2018, JAMA surgery.

[6]  G. Poston,et al.  The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  R. Riechelmann,et al.  Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)? , 2018, Journal of surgical oncology.

[8]  M. Gonen,et al.  The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer , 2018, Annals of Surgical Oncology.

[9]  U. Shin,et al.  Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer? , 2017, Annals of coloproctology.

[10]  Jeffrey S. Morris,et al.  Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes , 2017, Clinical Cancer Research.

[11]  W. Scheithauer,et al.  Exploring the effect of primary tumor sidedness on therapeutic efficacy across treatment lines in patients with metastatic colorectal cancer: analysis of FIRE-3 (AIOKRK0306) , 2017, Oncotarget.

[12]  M. Choti,et al.  Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases , 2017, Annals of surgery.

[13]  P. Gibbs,et al.  Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes , 2017, European journal of cancer.

[14]  J. Pignon,et al.  Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials † , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Jonathan H. Chen,et al.  Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. , 2017, The New England journal of medicine.

[16]  D. Solit,et al.  Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases , 2017, Cancer.

[17]  S. Barni,et al.  Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-analysis , 2017, JAMA oncology.

[18]  J. Vauthey,et al.  Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection , 2017, Surgery.

[19]  J. Vauthey,et al.  Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases , 2016, Annals of surgery.

[20]  T. Pawlik,et al.  The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis , 2016, Journal of surgical oncology.

[21]  U. Güller,et al.  Better survival in right-sided versus left-sided stage I - III colon cancer patients , 2016, BMC Cancer.

[22]  H. Lenz,et al.  Primary tumor location as a prognostic factor in metastatic colorectal cancer. , 2015, Journal of the National Cancer Institute.

[23]  L. Capussotti,et al.  Resection of Liver Metastases From Colorectal Mucinous Adenocarcinoma: Is This a Different Disease? Results of a Case-Control Study , 2014, Annals of surgery.

[24]  Sejong Bae,et al.  A Study of Effects of MultiCollinearity in the Multivariable Analysis. , 2014, International journal of applied science and technology.

[25]  M. Stauch,et al.  Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial , 2014, Journal of Cancer Research and Clinical Oncology.

[26]  H. Seo,et al.  Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. , 2014, World journal of gastroenterology.

[27]  J. Shindoh,et al.  Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases , 2012, Annals of surgery.

[28]  A. Viale,et al.  Comparative genomic analysis of primary versus metastatic colorectal carcinomas. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Maureen A. Smith,et al.  Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results--Medicare data. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Gonen,et al.  Effect of Postoperative Morbidity on Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer , 2008, Annals of surgery.

[31]  G. Poston,et al.  Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  V. Heinemann,et al.  The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials. , 2017, European journal of cancer.

[33]  Yuhree Kim,et al.  KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases , 2016, Annals of Surgical Oncology.